Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice
Background: The anti- Mycobacterium avium complex (MAC) antibody test measures levels of IgA antibody against the glycopeptidolipid (GPL) core in the bacterial cell walls and is a useful clinical indicator of nontuberculous mycobacterium pulmonary disease (NTM-PD). However, it is not currently possi...
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2022-11-01
|
| Series: | Therapeutic Advances in Respiratory Disease |
| Online Access: | https://doi.org/10.1177/17534666221138002 |
| _version_ | 1797853292296929280 |
|---|---|
| author | Takuya Iwasaki Fumihiro Yamaguchi Makoto Hayashi Hitoshi Kobayashi Kento Hirata Kenta Miyo Chika Kondo Mamiko Kanzaki Kazusawa Tei Takashi Abe Shunsuke Sakakura Daisuke Inoue Yohei Yamazaki Hidetsugu Tateno Takuya Yokoe Yusuke Shikama |
| author_facet | Takuya Iwasaki Fumihiro Yamaguchi Makoto Hayashi Hitoshi Kobayashi Kento Hirata Kenta Miyo Chika Kondo Mamiko Kanzaki Kazusawa Tei Takashi Abe Shunsuke Sakakura Daisuke Inoue Yohei Yamazaki Hidetsugu Tateno Takuya Yokoe Yusuke Shikama |
| author_sort | Takuya Iwasaki |
| collection | DOAJ |
| description | Background: The anti- Mycobacterium avium complex (MAC) antibody test measures levels of IgA antibody against the glycopeptidolipid (GPL) core in the bacterial cell walls and is a useful clinical indicator of nontuberculous mycobacterium pulmonary disease (NTM-PD). However, it is not currently possible to diagnose the disease using anti-MAC antibodies alone. Objectives: The study aim was to assess the efficacy of the combination of anti-MAC antibodies and clinical findings for diagnosing potential NTM-PD. Methods: This cross-sectional study included 938 patients tested using the anti-MAC antibody. NTM-PD was diagnosed by multiple positive cultures of the same species in sputum samples. Multivariate logistic regression models were used to identify the clinical factors related to NTM-PD. Results: Overall, 19.6% (184/938) of participants were diagnosed with NTM-PD. In multivariate analysis, positive anti-MAC antibodies, low body mass index, absence of malignancy, and cavity-forming lung lesions were significantly associated with NTM-PD at diagnosis. The positive rates of the anti-MAC antibody test were 79.4% (135/170) for MAC and 55.6% (5/9) for Mycobacterium abscessus complex, respectively. Conclusions: Bronchoscopic examinations should be performed especially in certain types of individuals from whom sputum samples cannot be obtained. Anti-MAC antibodies are also positive in patients other than those harboring MAC, but the rate may be low because of the different components in GPLs. |
| first_indexed | 2024-04-09T19:47:11Z |
| format | Article |
| id | doaj.art-02c8c42a45e746ae8790579768f48558 |
| institution | Directory Open Access Journal |
| issn | 1753-4666 |
| language | English |
| last_indexed | 2024-04-09T19:47:11Z |
| publishDate | 2022-11-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Respiratory Disease |
| spelling | doaj.art-02c8c42a45e746ae8790579768f485582023-04-03T13:08:55ZengSAGE PublishingTherapeutic Advances in Respiratory Disease1753-46662022-11-011610.1177/17534666221138002Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practiceTakuya IwasakiFumihiro YamaguchiMakoto HayashiHitoshi KobayashiKento HirataKenta MiyoChika KondoMamiko KanzakiKazusawa TeiTakashi AbeShunsuke SakakuraDaisuke InoueYohei YamazakiHidetsugu TatenoTakuya YokoeYusuke ShikamaBackground: The anti- Mycobacterium avium complex (MAC) antibody test measures levels of IgA antibody against the glycopeptidolipid (GPL) core in the bacterial cell walls and is a useful clinical indicator of nontuberculous mycobacterium pulmonary disease (NTM-PD). However, it is not currently possible to diagnose the disease using anti-MAC antibodies alone. Objectives: The study aim was to assess the efficacy of the combination of anti-MAC antibodies and clinical findings for diagnosing potential NTM-PD. Methods: This cross-sectional study included 938 patients tested using the anti-MAC antibody. NTM-PD was diagnosed by multiple positive cultures of the same species in sputum samples. Multivariate logistic regression models were used to identify the clinical factors related to NTM-PD. Results: Overall, 19.6% (184/938) of participants were diagnosed with NTM-PD. In multivariate analysis, positive anti-MAC antibodies, low body mass index, absence of malignancy, and cavity-forming lung lesions were significantly associated with NTM-PD at diagnosis. The positive rates of the anti-MAC antibody test were 79.4% (135/170) for MAC and 55.6% (5/9) for Mycobacterium abscessus complex, respectively. Conclusions: Bronchoscopic examinations should be performed especially in certain types of individuals from whom sputum samples cannot be obtained. Anti-MAC antibodies are also positive in patients other than those harboring MAC, but the rate may be low because of the different components in GPLs.https://doi.org/10.1177/17534666221138002 |
| spellingShingle | Takuya Iwasaki Fumihiro Yamaguchi Makoto Hayashi Hitoshi Kobayashi Kento Hirata Kenta Miyo Chika Kondo Mamiko Kanzaki Kazusawa Tei Takashi Abe Shunsuke Sakakura Daisuke Inoue Yohei Yamazaki Hidetsugu Tateno Takuya Yokoe Yusuke Shikama Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice Therapeutic Advances in Respiratory Disease |
| title | Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| title_full | Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| title_fullStr | Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| title_full_unstemmed | Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| title_short | Combination of anti-glycopeptidolipid-core IgA antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| title_sort | combination of anti glycopeptidolipid core iga antibody and clinical features for diagnosing potential nontuberculous mycobacterium pulmonary disease in routine practice |
| url | https://doi.org/10.1177/17534666221138002 |
| work_keys_str_mv | AT takuyaiwasaki combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT fumihiroyamaguchi combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT makotohayashi combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT hitoshikobayashi combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT kentohirata combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT kentamiyo combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT chikakondo combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT mamikokanzaki combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT kazusawatei combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT takashiabe combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT shunsukesakakura combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT daisukeinoue combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT yoheiyamazaki combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT hidetsugutateno combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT takuyayokoe combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice AT yusukeshikama combinationofantiglycopeptidolipidcoreigaantibodyandclinicalfeaturesfordiagnosingpotentialnontuberculousmycobacteriumpulmonarydiseaseinroutinepractice |